Abstract

Rapid development of antibiotic-resistant Neisseria gonorrhoeae hampers effective control efforts (the current recommended therapy is a single 500-mg

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call